|
10 May 2007 Poster Session 1: 12:30-14:00
P002 Peptide degradation is a critical determinant for cell-penetrating peptide uptake.
C. Palm, M. Jayamanne, M. Kjellander and M. Hällbrink
P003 Characterisation of the uptake of octaarginine in different cell types in the absence or presence of the cholesterol sequestering agent methyl-b-cyclodextrin
C. Watkins, M. Fretz, J. Hickey, B. Shi, D. Schmaljohann, S. Futaki and A. Jones
P004 Characterization of the N-terminal segment used by the barley yellow dwarf virus movement protein
S.R. Dennison, F. Harris, K. Brandenburg and D.A. Phoenix
P005 Impact of the carrier nature on the cellular uptake efficiency and the intracellular localization
B. Aussedat, E. Dupont, S. Sagan, A. Joliot, S. Lavielle, G. Chassaing and F. Burlina
P006 (R-Ahx-R)4 cell-penetrating peptide enhances the delivery of antisense morpholino oligomers
H.M. Moulton, N. Jearawiriyapaisarn, S. Fletcher, G. McClorey, B.W. Neuman, A. Amantana, S. Abes, D.A. Stein, R. Kole, S. Wilton, M.J. Buchmeier, B. Lebleu and P.L. Iversen
P007 New promising CPP derived from human calcitonin: application and uptake mechanism
R. Rennert, C. Walther, A.G. Beck-Sickinger and I. Neundorf
P008 Understanding histidine rich amphipathic peptide mediated gene delivery using solid-state NMR techniques
A.J. Mason, A. Kichler and B. Bechinger
P009 Oligoarginine-adenosine conjugates as efficient inhibitors of Rho kinase
H. Räägel, M. Lust, A. Uri and M. Pooga
P010 Tat peptide: structure/activity studies
A. Subrizi, A. Urtti and M. Antopolsky
P011 Clathrin-mediated endocytosis of proteins containing a GST-fold
M.J. Morris, S.J. Craig, M.G. Casarotto and P.G. Board
P012 An HIV-1 Tat peptide enters Hela cells through clathrin-mediated endocytosis, and not by direct plasma membrane penetration
P.J. Sinko, X. Zhang, Y. Jin, S. Pooyan, S. Gunaseelan and L. Wan
P013 Transportan- and TP10-induced protein cellular delivery is flotillin-independent
P. Säälik, K. Padari, A. Niinep, M. Hansen, Ü. Langel and M. Pooga
P014 Analytical analyses of CPP cellular up-take for studying PDZ domains in vivo.
P. Boisguerin, J. Mueller and R. Volkmer
P015 Development of artificial cell penetrating peptide using “HIT” technology
R. Vinayak and H. Ikeda
P016 Monolayer investigations into the cell penetrating peptide Tat
S.R. Dennison, R.D. Baker, I.D. Nicholl and D.A. Phoenix
P017 Intracellular fate of CPP disulfide-linked PNAs
F. Boutimah-Hamoudi and T.E. Saison-Behmoaras
P021 Cell-penetrating peptide–polymer conjugates with strongly increased bioactivity inside the cell
F. Duchardt, I. Ruttekolk, R. Fischer, K.-H. Wiesmüller and R. Brock
|
|
11 May 2007 Poster Session 2: 12:30-14:00
P018 Proteoglycans as internalizing receptors – elucidating their physiological role and exploiting the route for drug delivery
A. Wittrup, S. Sandgren, J. Lilja, P. Bengtson, K. Svensson, C. Bratt and M. Belting
P019 Membrane active peptide enhances Tat-mediated gene delivery
A.F. Saleh, H. Aojula and A. Pluen
P020 Targeting the MHC class-II presentation pathway in allergy vaccine development
C. Rhyner, T. Kündig, C.A. Akdis and R. Crameri
P022 Peptidomimetics with b-peptoid residues for delivery of siRNA
C. Foged, C.A. Olsen, S. Frokjaer and H.M. Nielsen
P023 Synthesis and studies on the cell-penetrating ability of fusogenic peptide for the delivery of ODN or siRNA
J.-R. Bertrand, E. Illyés, M. Hollósi, I. Laczkó, S. Bottka, G.K. Tóth and C. Malvy
P024 Influence of the peptide structure upon the biological activity of PNA–peptide conjugates in cells with natural nucleic acid level and transfected cells.
J. Oehlke, Y. Turner, G. Wallukat, S. Pritz and M. Bienert
P026 An oligoarginine-based cargo-transporter system for improving drug intestinal absorption: utilization of self-cleavable peptide linkers
K. Takayama, Y. Hayashi, Y. Suehisa, T. Fujita, A. Yamamoto, S. Futaki and Y. Kiso
P027 ZEBRA as a new delivery system for therapeutic proteins
R. Rothe, A. Villegas-Mendez, L. Liguori, B. Marques and J.L. Lenormand
P028 Synthesis, application and quantitation of clamp-bioshuttle-carriers for plasmid delivery into nuclei of prostate cancer cells
R. Pipkorn, W. Waldeck, B. Didinger and K. Braun
P029 Cellular delivery of nucleic acids by a non-covalently attached peptide carrier: quantitative analysis of cellular uptake and biological effect
S.D. Laufer, A.L. Recke, A. Trampe, S. Veldhoen and T. Restle
P030 S413-PV cell penetrating peptide-based strategies for the intracellular delivery of nucleic acids
S. Trabulo, M. Mano, H. Faneca, A.L. Cardoso, S. Simões and M.C. Pedroso de Lima
P031 Cancer cell targeted therapy using chimaeric proteins
S. Potala and R.S. Verma
P032 Characterization of a novel cytotoxic cell-penetrating peptide derived from the p14ARF protein
H.J. Johansson, S. EL-Andaloussi, T. Holm and Ü. Langel
P033 Peptide–PNA conjugates by employing chemo-selective click chemistry
K. Gogoi, M.V. Mane, S.S. Kunte and V.A. Kumar
P034 Drug binding motif conjugated to Tat peptide traffics the delivery of doxorubicin in human leukaemia cells
Z. Zheng, H. Aojula and D. Clarke
|